M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis

Multi drug resistance protein 1 (MDR1) expression on tumor cells has been widely investigated in context of drug resistance. However, the role of MDR1 on the immune cell infiltrate of solid tumors remains unknown. The aim of this study was to analyze the prognostic significance of a MDR1+ immune cel...

Full description

Bibliographic Details
Main Authors: Susann Badmann, Sabine Heublein, Doris Mayr, Anna Reischer, Yue Liao, Thomas Kolben, Susanne Beyer, Anna Hester, Christine Zeder-Goess, Alexander Burges, Sven Mahner, Udo Jeschke, Fabian Trillsch, Bastian Czogalla
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/9/5/1224
_version_ 1827716833640185856
author Susann Badmann
Sabine Heublein
Doris Mayr
Anna Reischer
Yue Liao
Thomas Kolben
Susanne Beyer
Anna Hester
Christine Zeder-Goess
Alexander Burges
Sven Mahner
Udo Jeschke
Fabian Trillsch
Bastian Czogalla
author_facet Susann Badmann
Sabine Heublein
Doris Mayr
Anna Reischer
Yue Liao
Thomas Kolben
Susanne Beyer
Anna Hester
Christine Zeder-Goess
Alexander Burges
Sven Mahner
Udo Jeschke
Fabian Trillsch
Bastian Czogalla
author_sort Susann Badmann
collection DOAJ
description Multi drug resistance protein 1 (MDR1) expression on tumor cells has been widely investigated in context of drug resistance. However, the role of MDR1 on the immune cell infiltrate of solid tumors remains unknown. The aim of this study was to analyze the prognostic significance of a MDR1+ immune cell infiltrate in epithelial ovarian cancer (EOC) and to identify the MDR1+ leucocyte subpopulation. MDR1 expression was analyzed by immunohistochemistry in 156 EOC samples. In addition to MDR1+ cancer cells, we detected a MDR1+ leucocyte infiltrate (high infiltrate >4 leucocytes per field of view). Correlations and survival analyses were calculated. To identify immune cell subpopulations immunofluorescence double staining was performed. The MDR1+ leucocyte infiltrate was associated with human epidermal growth factor receptor 2 (HER2) (cc = 0.258, <i>p</i> = 0.005) and tumor-associated mucin 1 (TA-MUC1) (cc = 0.202, <i>p</i> = 0.022) expression on cancer cells. A high MDR1+ leucocyte infiltrate was associated with impaired survival, especially in patients whose carcinoma showed either serous histology (median OS 28.80 vs. 50.64 months, <i>p</i> = 0.027, n = 91) or TA-MUC1 expression (median OS 30.60 vs. 63.36 months, <i>p</i> = 0.015, n = 110). Similar findings for PFS suggest an influence of MDR1+ immune cells on the development of chemoresistance. A Cox regression analysis confirmed the independency of a high MDR1+ leucocyte infiltrate as prognostic factor. M2 macrophages were identified as main part of the MDR1+ leucocyte infiltrate expressing MDR1 as well as the M2 marker CD163 and the pan-macrophage marker CD68. Infiltration of MDR1+ leucocytes, mostly M2 macrophages, is associated with poor prognosis of EOC patients. Further understanding of the interaction of M2 macrophages, MDR1 and TA-MUC1 appears to be a key aspect to overcome chemoresistance in ovarian cancer.
first_indexed 2024-03-10T19:48:23Z
format Article
id doaj.art-1faef99a4309448b9fbe469943d3324c
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-10T19:48:23Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-1faef99a4309448b9fbe469943d3324c2023-11-20T00:34:17ZengMDPI AGCells2073-44092020-05-0195122410.3390/cells9051224M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor PrognosisSusann Badmann0Sabine Heublein1Doris Mayr2Anna Reischer3Yue Liao4Thomas Kolben5Susanne Beyer6Anna Hester7Christine Zeder-Goess8Alexander Burges9Sven Mahner10Udo Jeschke11Fabian Trillsch12Bastian Czogalla13Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyInstitute of Pathology, Faculty of Medicine, LMU Munich, Thalkirchner Straße 36, 80337 Munich, GermanyDepartment of Medicine III, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyDepartment of Obstetrics and Gynecology, University Hospital, LMU Munich, Marchioninistraße 15, 81377 Munich, GermanyMulti drug resistance protein 1 (MDR1) expression on tumor cells has been widely investigated in context of drug resistance. However, the role of MDR1 on the immune cell infiltrate of solid tumors remains unknown. The aim of this study was to analyze the prognostic significance of a MDR1+ immune cell infiltrate in epithelial ovarian cancer (EOC) and to identify the MDR1+ leucocyte subpopulation. MDR1 expression was analyzed by immunohistochemistry in 156 EOC samples. In addition to MDR1+ cancer cells, we detected a MDR1+ leucocyte infiltrate (high infiltrate >4 leucocytes per field of view). Correlations and survival analyses were calculated. To identify immune cell subpopulations immunofluorescence double staining was performed. The MDR1+ leucocyte infiltrate was associated with human epidermal growth factor receptor 2 (HER2) (cc = 0.258, <i>p</i> = 0.005) and tumor-associated mucin 1 (TA-MUC1) (cc = 0.202, <i>p</i> = 0.022) expression on cancer cells. A high MDR1+ leucocyte infiltrate was associated with impaired survival, especially in patients whose carcinoma showed either serous histology (median OS 28.80 vs. 50.64 months, <i>p</i> = 0.027, n = 91) or TA-MUC1 expression (median OS 30.60 vs. 63.36 months, <i>p</i> = 0.015, n = 110). Similar findings for PFS suggest an influence of MDR1+ immune cells on the development of chemoresistance. A Cox regression analysis confirmed the independency of a high MDR1+ leucocyte infiltrate as prognostic factor. M2 macrophages were identified as main part of the MDR1+ leucocyte infiltrate expressing MDR1 as well as the M2 marker CD163 and the pan-macrophage marker CD68. Infiltration of MDR1+ leucocytes, mostly M2 macrophages, is associated with poor prognosis of EOC patients. Further understanding of the interaction of M2 macrophages, MDR1 and TA-MUC1 appears to be a key aspect to overcome chemoresistance in ovarian cancer.https://www.mdpi.com/2073-4409/9/5/1224MDR1M2 Macrophagesovarian cancerTA-MUC1prognosis
spellingShingle Susann Badmann
Sabine Heublein
Doris Mayr
Anna Reischer
Yue Liao
Thomas Kolben
Susanne Beyer
Anna Hester
Christine Zeder-Goess
Alexander Burges
Sven Mahner
Udo Jeschke
Fabian Trillsch
Bastian Czogalla
M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
Cells
MDR1
M2 Macrophages
ovarian cancer
TA-MUC1
prognosis
title M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
title_full M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
title_fullStr M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
title_full_unstemmed M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
title_short M2 Macrophages Infiltrating Epithelial Ovarian Cancer Express MDR1: A Feature That May Account for the Poor Prognosis
title_sort m2 macrophages infiltrating epithelial ovarian cancer express mdr1 a feature that may account for the poor prognosis
topic MDR1
M2 Macrophages
ovarian cancer
TA-MUC1
prognosis
url https://www.mdpi.com/2073-4409/9/5/1224
work_keys_str_mv AT susannbadmann m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT sabineheublein m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT dorismayr m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT annareischer m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT yueliao m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT thomaskolben m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT susannebeyer m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT annahester m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT christinezedergoess m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT alexanderburges m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT svenmahner m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT udojeschke m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT fabiantrillsch m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis
AT bastianczogalla m2macrophagesinfiltratingepithelialovariancancerexpressmdr1afeaturethatmayaccountforthepoorprognosis